How should we view the A-share market performance on April 1, 2026?

Another seawater desalination plant has been damaged—though this time it appears to be Iran’s. Both sides are retaliating in kind; they’re seizing the opportunity to launch more strikes before the conflict ends. Three vessels from Dongda (East China) have successfully passed through the Strait of Hormuz: This fact is verifiable. As for its impact, however, the symbolic significance outweighs the practical implications—given the scale of our economy, we require far more shipping capacity. The National Bureau of Statistics released the March manufacturing PMI at 50.4—slightly above expectations and marking a return to expansion territory. This PMI index is one of the most accessible macroeconomic indicators for ordinary investors: readings above 50 signal improvement, while those below 50 indicate stagnation—simple and intuitive. An IPO of a leading commercial aerospace company has been suspended: It is ‘suspended’, not ‘terminated’—meaning it may resume later. That said, the execution was subpar: such a critical process contained embarrassingly basic errors—truly reminiscent of an amateurish, makeshift operation. A prominent energy storage stock reported disappointing earnings: Q4 results were disastrous—far from ideal. Investors holding related securities should remain vigilant about associated risks. Many readers have repeatedly asked about a certain potash company: In fact, everything unfolded exactly as anticipated. Below is my forecast issued when the earnings preview was released: And here is the official annual report: Without undue modesty, that earlier analysis sufficed—it aligned completely with the actual figures disclosed in the annual report. In other words, this was an earnings report that fell short of market expectations yet fully matched my personal forecast. The unexpectedly high net profit growth stemmed almost entirely from tax expense treatment. Fundamentally, the company remains sound—but its net profit growth wasn’t as explosive as signaled in the earnings preview. Hence, investors should temper their 2026 earnings expectations accordingly. Earlier, I remarked that practicing professional value investing ideally requires foundational competence in CPA-level accounting—a threshold many investors deem excessively high, even suspecting I deliberately exaggerate investment difficulty. Yet reality is stark: without rigorous analytical capability and solid financial knowledge, it’s extremely difficult to reach forward-looking conclusions—especially in complex cases like this. Even if one somehow arrives at the right conclusion, lack of confidence in one’s own ability renders it practically useless for guiding real-world investment decisions. Investing is profoundly rewarding—particularly when you meticulously dissect publicly available information, gradually uncover fragments of truth, and then witness those insights validated days or months later. Profitability aside, that moment of revelation delivers an electrifying, head-to-toe rush—the kind of exhilaration学霸 (top-tier students) will instantly recognize: akin to solving the final, most challenging problem on the national college entrance exam (Gaokao). Commodities: Amid easing expectations regarding the ongoing conflict, crude oil prices declined, while gold, silver, and other non-ferrous metals rose—silver, exhibiting the highest elasticity, surged over 4%. Gold approached the RMB 4,700 per gram mark. The physical gold bars I purchased recently via grid trading have already turned profitable.

Global and Chinese Avobenzone Market Operations and Investment Risk Outlook Report (2025–2031)

5.9.5 Qiangli New Materials – Latest Corporate Updates 5.10 Klöckner & Co (Klöckner) 5.10.1 Klöckner & Co – Basic Information, Avobenzone Production Bases, Sales Regions, Competitors, and Market Position 5.10.2 Klöckner & Co – Avobenzone Product Specifications, Parameters, and Market Applications 5.10.3 Klöckner & Co – Avobenzone Sales Volume, Revenue, Pricing, and Gross Margin (2020–2025) 5.10.4 Klöckner & Co – Company Profile and Core Business Activities 5.10.5 Klöckner & Co – Latest Corporate Updates 5.11 Merck KGaA 5.11.1 Merck KGaA – Basic Information, Avobenzone Production Bases, Sales Regions, Competitors, and Market Position 5.11.2 Merck KGaA – Avobenzone Product Specifications, Parameters, and Market Applications 5.11.3 Merck KGaA – Avobenzone Sales Volume, Revenue, Pricing, and Gross Margin (2020–2025) 5.11.4 Merck KGaA – Company Profile and Core Business Activities 5.11.5 Merck KGaA – Latest Corporate Updates 5.12 Croda International 5.12.1 Croda International – Basic Information, Avobenzone Production Bases, Sales Regions, Competitors, and Market Position 5.12.2 Croda International – Avobenzone Product Specifications, Parameters, and Market Applications 5.12.3 Croda International – Avobenzone Sales Volume, Revenue, Pricing, and Gross Margin (2020–2025) 5.12.4 Croda International – Company Profile and Core Business Activities 5.12.5 Croda International – Latest Corporate Updates 5.13 Ashland Global Holdings 5.13.1 Ashland Global Holdings – Basic Information, Avobenzone Production Bases, Sales Regions, Competitors, and Market Position 5.13.2 Ashland Global Holdings – Avobenzone Product Specifications, Parameters, and Market Applications 5.13.3 Ashland Global Holdings – Avobenzone Sales Volume, Revenue, Pricing, and Gross Margin (2020–2025) 5.13.4 Ashland Global Holdings – Company Profile and Core Business Activities 5.13.5 Ashland Global Holdings – Latest Corporate Updates 5.14 Royal DSM N.V. 5.14.1 Royal DSM N.V. – Basic Information, Avobenzone Production Bases, Sales Regions, Competitors, and Market Position 5.14.2 Royal DSM N.V. – Avobenzone Product Specifications, Parameters, and Market Applications 5.14.3 Royal DSM N.V. – Avobenzone Sales Volume, Revenue, Pricing, and Gross Margin (2020–2025) 5.14.4 Royal DSM N.V. – Company Profile and Core Business Activities 5.14.5 Royal DSM N.V. – Latest Corporate Updates 6 Analysis by Avobenzone Product Type 6.1 Global Avobenzone Sales by Product Type (2020–2031) 6.1.1 Global Avobenzone Sales and Market Share by Product Type (2020–2025) 6.1.2 Global Avobenzone Sales Forecast by Product Type (2026–2031) 6.2 Global Avobenzone Revenue by Product Type (2020–2031) 6.2.1 Global Avobenzone Revenue and Market Share by Product Type (2020–2025)

Ashland Inc. Remains a Buy with Strong Q4FY26 Results and Potential Takeover Interest

1 day ago

Ashland Inc. retains a 'Buy' rating after meeting Q4FY26 revenue and EBITDA targets, with investors eyeing potential acquisition amid plans for an FY2027 turnaround via cost restructuring.

Pluang

2026-04-01

Ashland Inc Stock: Specialty Chemicals Leader Faces Evolving Industrial Demands in 2026

2026-04-04

Allspring Global Investments Reduces Stake in Ashland Inc. to $25.69 Million

2026-04-06

Ashland Raises Prices Across Product Lines Amid Cost Pressures

2026-04-11

Ashland Inc. (NYSE:ASH) Given Consensus Rating of "Hold" by Analysts

2026-04-13

Massachusetts Financial Services Co. Lowers Stock Position in Ashland Inc.